to all longtime holders and newbies

THe sir spheres works well with all the new generation antigenesis inhibitors which diminish tumor growth in the liver. five or six different big bio pharmas have these drugs which work well with sir spheres in prolonging survival times more significantly than other biotechs with market caps in the billion dollar range and much less significant products. At srx market cap of $230 million USD the upside in sp is quite big and when the shares get rolling up again you will pay over $8+ with the tiny float.Five pharma all chasing the same company is going to create a big premium as Cephalon bid $5 , five yrs ago when the company was just starting. At this point srx is worth at least 3x what it was worth to an acquirer then at $5. The big boys will be coming back soon and when they do i want to be in already..